{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:34:01Z","timestamp":1793655241678,"version":"4.5.1"},"reference-count":191,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    The Epstein-Barr virus (EBV) is a ubiquitous human pathogen linked to various diseases, including infectious mononucleosis and multiple types of cancer. To control and eliminate EBV, the host\u2019s immune system deploys its most potent defenses, including pattern recognition receptors, Natural Killer cells, CD8\n                    <jats:sup>+<\/jats:sup>\n                    and CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells, among others. The interaction between EBV and the human immune system is complex and multifaceted. EBV employs a variety of strategies to evade detection and elimination by both the innate and adaptive immune systems. This demonstrates EBV\u2019s mastery of navigating the complexities of the immunological landscape. Further investigation into these complex mechanisms is imperative to advance the development of enhanced therapeutic approaches with heightened efficacy. This review provides a comprehensive overview of various mechanisms known to date, employed by the EBV to elude the immune response, while establishing enduring latent infections or instigate its lytic replication.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2024.1297994","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:11:11Z","timestamp":1707264671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":98,"title":["Epstein-Barr virus: the mastermind of immune chaos"],"prefix":"10.3389","volume":"15","author":[{"given":"Jean de Melo","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo de Castro","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemilson Soares","family":"Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global\u00a0burden of Epstein\u2013Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-68945-6_9","article-title":"\u201cEpidemiology of EBV infection\u201d","volume":"20","author":"Rochford","year":"2009","journal-title":"DNA Tumor Viruses."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT\u2019S LYMPHOMA","volume":"283","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary epstein-barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: Biology and clinical disease","volume":"185","author":"Damania","year":"2022","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2020-0005","article-title":"Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein-Barr virus in Canada: A cross-sectional study","volume":"5","author":"Mabilangan","year":"2020","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v14112372","article-title":"How EBV infects: the tropism and underlying molecular mechanism for viral infection","volume":"14","author":"Bu","year":"2022","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01597-14","article-title":"Epstein-Barr Virus Glycoprotein gB and gHgL Can Mediate Fusion and Entry in trans , and Heat Can Act as a Partial Surrogate for gHgL and Trigger a Conformational Change in gB","volume":"88","author":"Chesnokova","year":"2014","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00445-07","article-title":"Epstein-barr virus entry","volume":"81","author":"Hutt-fletcher","year":"2007","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/v15030726","article-title":"EBV reactivation from latency is a degrading experience for the host","volume":"15","author":"Casco","year":"2023","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00540-23","article-title":"Upregulation of IQGAP2 by EBV transactivator Rta and its influence on EBV life cycle","volume":"97","author":"Lin","year":"2023","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/JVI.01921-15","article-title":"Epstein-barr virus BZLF1-mediated downregulation of proinflammatory factors is essential for optimal lytic viral replication","volume":"90","author":"Li","year":"2016","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Rev Med Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of epstein-barr virus","volume":"79","author":"Laichalk","year":"2005","journal-title":"In Vivo. J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/v13122344","article-title":"Molecular basis of epstein-barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-021-01215-3","article-title":"Landscape of EBV-positive gastric cancer","volume":"24","author":"Saito","year":"2021","journal-title":"Gastric Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.935205","article-title":"EBV infection and its regulated metabolic reprogramming in nasopharyngeal tumorigenesis","volume":"12","author":"Yang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06152-z","article-title":"A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types","volume":"48","author":"Soltani","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-9-34","article-title":"The role of EBV in the pathogenesis of Burkitt\u2019s Lymphoma: an Italian hospital based survey","volume":"9","author":"Pannone","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060163","article-title":"Epstein barr virus-associated hodgkin lymphoma","volume":"10","author":"Carbone","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B22","first-page":"57","article-title":"\u201cCurrent progress in EBV-associated B-cell lymphomas.,\u201d","volume-title":"Advances in experimental medicine and biology","author":"Pei","year":"2017"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol"},{"key":"B24","article-title":"\u201cImmune evasion by Epstein-Barr virus.,\u201d","volume-title":"Current topics in microbiology and immunology","author":"Ressing","year":"2015"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28479-2","article-title":"EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137265","article-title":"Virus-mediated inhibition of apoptosis in the context of EBV-associated diseases: molecular mechanisms and therapeutic perspectives","volume":"23","author":"Wy\u017cewski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00288-12","article-title":"Transcriptome changes induced by epstein-barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma","volume":"3","author":"Shair","year":"2012","journal-title":"mBio"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216898","article-title":"Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL","volume":"14","author":"Nagel","year":"2019","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1006\/VIRO.1994.1309","article-title":"Epstein-barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection","volume":"201","author":"Tarodi","year":"1994","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1001236","article-title":"Structural basis for apoptosis inhibition by epstein-barr virus BHRF1","volume":"6","author":"Kvansakul","year":"2010","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/S41418-019-0435-1","article-title":"EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins","volume":"27","author":"Fitzsimmons","year":"2020","journal-title":"Cell Death Differ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of stat3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2019.52.7.152","article-title":"Highlighted STAT3 as a potential drug target for cancer therapy","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2019.11.017","article-title":"STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes","volume":"540","author":"Koganti","year":"2020","journal-title":"Virology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.5.954","article-title":"Epstein-Barr virus RNA confers resistance to interferon-a-induced apoptosis in Burkitt\u2019s lymphoma","volume":"21","author":"Nanbo","year":"2002","journal-title":"EMBO"},{"key":"B36","first-page":"181","article-title":"\u201cEBV noncoding RNAs","volume-title":"Current topics in microbiology and immunology","author":"Skalsky","year":"2015"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.01.002","article-title":"Virus-encoded microRNAs","volume":"411","author":"Grundhoff","year":"2011","journal-title":"Virology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2011.07.007","article-title":"The role of microRNAs in Epstein-Barr virus latency and lytic reactivation","volume":"13","author":"Forte","year":"2011","journal-title":"Microbes Infect"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.2.805","article-title":"Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus","volume":"78","author":"Lerner","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000221","article-title":"BART miRNAs: An unimaginable force in the development of nasopharyngeal carcinoma","volume":"26","author":"Wang","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00376-4","article-title":"Targeting the signaling in Epstein\u2013Barr virus-associated diseases: mechanism, regulation, and clinical study","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4161\/CC.20771","article-title":"Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53","volume":"11","author":"Li","year":"2012","journal-title":"Cell Cycle"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.01.025","article-title":"Epstein-barr virus-encoded miR-BART20-5p inhibits t-bet translation with secondary suppression of p53 in invasive nasal NK\/T-cell lymphoma","volume":"182","author":"Lin","year":"2013","journal-title":"Am J Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.111","article-title":"More than just a T-box: The role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases","volume":"3","author":"Ji","year":"2011","journal-title":"Immunotherapy"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761920","article-title":"Expression regulation and function of T-bet in NK cells","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28338","article-title":"Epstein-Barr virus miR-BART2-5p and miR-BART11-5p regulate cell proliferation, apoptosis, and migration by targeting RB and p21 in gastric carcinoma","volume":"95","author":"Zhao","year":"2023","journal-title":"J Med Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1\u03b2 Production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 inflammasome\u2014A key player in antiviral responses","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11262-021-01882-5","article-title":"Epstein\u2013Barr virus miR-BART4-3p regulates cell proliferation, apoptosis, and migration by targeting AXL in gastric carcinoma","volume":"58","author":"Zhao","year":"2022","journal-title":"Virus Genes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03639-14","article-title":"Profiling of virus-encoded microRNAs in epstein-barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis","volume":"89","author":"Shinozaki-Ushiku","year":"2015","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2633-2636.1995","article-title":"An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the epstein-barr virus LMP gene","volume":"69","author":"Gahn","year":"1995"},{"key":"B53","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2020.12.022","article-title":"Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance","volume":"184","author":"Dheekollu","year":"2021","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.10.4512-4522.2000","article-title":"The minimal replicator of Epstein-Barr virus oriP","volume":"74","author":"Yates","year":"2000","journal-title":"J Virol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.8.1822-1832.1985","article-title":"A putative origin of replication of plasmids derived from epstein-barr virus is composed of two cis-acting components","volume":"5","author":"Reisman","year":"1985"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2021.198550","article-title":"Epstein-Barr virus noncoding small RNA (EBER1) induces cell proliferation by up-regulating cellular mitochondrial activity and calcium influx","volume":"305","author":"Ahmed","year":"2021","journal-title":"Virus Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00579-07","article-title":"Epstein-barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation","volume":"81","author":"Wu","year":"2007","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-70630-6_14","article-title":"LMP1 TRAFficking activates growth and survival pathways","volume":"597","author":"Soni","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-22822-8_8","article-title":"EBV persistence\u2014Introducing the virus","volume":"390","author":"Thorley-Lawson","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1128\/jvi.32.1.8-18.1979","article-title":"Identification of transcribed regions of epstein-barr virus DNA in burkitt lymphoma-derived cells","volume":"32","author":"Rymo","year":"1979","journal-title":"J Virol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00013-12","article-title":"Functions of the epstein-barr virus EBNA1 protein in viral reactivation and lytic infection","volume":"86","author":"Sivachandran","year":"2012","journal-title":"J Virol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6064\/2012\/438204","article-title":"The epstein-barr virus EBNA1 protein","volume":"2012","author":"Frappier","year":"2012","journal-title":"Scientifica (Cairo)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030120","article-title":"Gamma-herpesvirus latency requires T cell evasion during episome maintenance","volume":"3","author":"Bennett","year":"2005","journal-title":"PloS Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001151","article-title":"Epstein barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation","volume":"6","author":"Apcher","year":"2010","journal-title":"PloS Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.3.952","article-title":"Truncated mammalian notch1 activates CBF1\/RBPJk-repressed genes by a mechanism resembling that of epstein-barr virus EBNA2","volume":"16","author":"Hsieh","year":"1996","journal-title":"Molecular and Cellular Biology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.173.8.5121","article-title":"The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1","volume":"173","author":"Vine","year":"2004","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.8.5121","article-title":"The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ Lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1","volume":"173","author":"Vine","year":"2004","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3406\/rhs.1994.1189","article-title":"Virus, provirus and cancer","volume":"47","author":"Galperin","year":"1994","journal-title":"Rev Hist Sci Paris"},{"key":"B70","unstructured":"VakiliR\n            SabetF\n            Ahmadi GhezeldashtS\n            BoostaniR\n            Ra-FatpanahH\n            ShamsianA\n          Human T-lymphotropic virus type I (HTLV-I) proviral load and clinical features in Iranian HAM\/TSP patients2013"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01369-08","article-title":"mRNA translation regulation by the gly-ala repeat of epstein-barr virus nuclear antigen 1","volume":"83","author":"Apcher","year":"2009","journal-title":"J Virol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2004.08.003","article-title":"Epstein-Barr virus: Exploiting the immune system by interfering with defective ribosomal products","volume":"6","author":"Apcher","year":"2004","journal-title":"Microbes Infect"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitinproteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1 (antigen processing)","volume":"94","author":"Levitskaya","year":"1997"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.0060008","article-title":"The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity","volume":"6","author":"Schneider","year":"2008","journal-title":"PloS Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.22509.001","article-title":"Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection","volume":"6","author":"Price","year":"2017","journal-title":"Elife"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth746","article-title":"Identification of microRNAs of the herpesvirus family","volume":"2","author":"Pfeffer","year":"2005","journal-title":"Nat Methods"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-017-3996-5","article-title":"An update: Epstein-Barr virus and immune evasion via microRNA regulation","volume":"32","author":"Zuo","year":"2017","journal-title":"Virol Sin"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Sci (1979)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2023.07.010","article-title":"The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale","volume":"214","author":"Dinh","year":"2023","journal-title":"Biochimie"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3196","article-title":"Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells","volume":"105","author":"Pag\u00e8s","year":"2005","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2021.02.004","article-title":"RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells","volume":"557","author":"Yanagi","year":"2021","journal-title":"Virology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01446","article-title":"Latent membrane protein 1 of Epstein-Barr virus promotes RIG-I degradation mediated by proteasome pathway","volume":"9","author":"Xu","year":"2018","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08","article-title":"Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1","volume":"125","author":"Lin","year":"2015","journal-title":"Blood Journal"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002704","article-title":"The EBV\u00a0immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination","volume":"8","author":"Jochum","year":"2012","journal-title":"PloS Pathog"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02198","article-title":"Epstein Barr virus interleukin 10 suppresses anti-inflammatory phenotype in human monocytes","volume":"9","author":"Jog","year":"2018","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003960","article-title":"Epstein-barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling","volume":"10","author":"van Gent","year":"2014","journal-title":"PloS Pathog"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011186","article-title":"Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1","volume":"19","author":"Lui","year":"2023","journal-title":"PloS Pathog"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0611128104","article-title":"Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion","volume":"104","author":"Rowe","year":"2007","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903120","article-title":"EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection","volume":"186","author":"van Gent","year":"2011","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000021","article-title":"Silencing the shutoff protein of Epstein\u2013Barr virus in productively infected B cells points to (innate) targets for immune evasion","volume":"96","author":"Van Gent","year":"2015","journal-title":"J Gen Virol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2174\/1389203717666151201192124","article-title":"The structure-function relationships of complement receptor type 2 (CR2; CD21)","volume":"17","author":"Paul Hannan","year":"2016","journal-title":"Curr Protein Pept Sci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2022.108196","article-title":"How Epstein-Barr virus envelope glycoprotein gp350 tricks the CR2? A molecular dynamics study","volume":"114","author":"Bing\u00f6l","year":"2022","journal-title":"J Mol Graph Model"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHOM.2009.03.003","article-title":"Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells","volume":"5","author":"Nachmani","year":"2009","journal-title":"Cell Host Microbe"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03440-20","article-title":"Multiple viral micrornas regulate interferon release and signaling early during infection with epstein-barr virus","volume":"12","author":"Bouvet","year":"2021","journal-title":"mBio"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009217","article-title":"EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape","volume":"17","author":"Ungerleider","year":"2021","journal-title":"PloS Pathog"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20220417","article-title":"Regulation of B cell receptor signalling by Epstein\u2013Barr virus nuclear antigens","volume":"479","author":"Khasnis","year":"2022","journal-title":"Biochem J"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696605","article-title":"Current understanding of IL-37 in human health and disease","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: Current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front Immunol"},{"key":"B99","article-title":"\u201cThe latent membrane protein 1 (LMP1).,\u201d","volume-title":"Current topics in microbiology and immunology","author":"Kieser","year":"2015"},{"key":"B100","doi-asserted-by":"crossref","unstructured":"ElionDL\n            CookRS\n          Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment2018","DOI":"10.18632\/oncotarget.25626"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13022","article-title":"The molecular mechanism of RIG-I activation and signaling","volume":"304","author":"Thoresen","year":"2021","journal-title":"Immunol Rev"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"B103","article-title":"\u201cLatent membrane protein 2 (LMP2).,\u201d","volume-title":"Current topics in microbiology and immunology","author":"Cen","year":"2015"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.17.6185-6194.2000","article-title":"Class II transactivator: mastering the art of major histocompatibility complex expression","volume":"20","author":"Harton","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070256","article-title":"A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates","volume":"204","author":"Hislop","year":"2007","journal-title":"J Exp Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.semcancer.2008.10.008","article-title":"Epstein-B arr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple\u00a0gene products","volume":"18","author":"Ressing","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90216-9","article-title":"Epstein-barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis","volume":"50","author":"Tanner","year":"1987","journal-title":"Cell"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7060183","article-title":"Epstein\u2013barr virus and innate immunity: Friends or foes","volume":"7","author":"Jangra","year":"2019","journal-title":"Microorganisms"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS222413397","article-title":"Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) in innate immunity. TLRs, NLRs, and RLRs ligands as immunotherapeutic agents for hematopoietic diseases","volume":"22","author":"Wicherska-paw\u0142owska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22834-1_9","article-title":"Innate immune recognition of EBV","volume":"391","author":"L\u00fcnemann","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12985-021-01678-x","article-title":"Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections","volume":"18","author":"Gaglia","year":"2021","journal-title":"Virol J"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903120","article-title":"EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection","volume":"186","author":"van Gent","year":"2011","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903459","article-title":"EBV\u00a0latent membrane protein 1 is a negative regulator of TLR9","volume":"185","author":"Fathallah","year":"2010","journal-title":"J Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00613-16","article-title":"NF-\u03baB signaling regulates expression of epstein-barr virus BART microRNAs and long noncoding RNAs in nasopharyngeal carcinoma","volume":"90","author":"Verhoeven","year":"2016","journal-title":"J Virol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163981","article-title":"Serum and tissue level of TLR9 in EBV-associated oropharyngeal cancer","volume":"13","author":"St\u0119pie\u0144","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/v14061215","article-title":"MicroRNA regulation of human herpesvirus latency","volume":"14","author":"Chen","year":"2022","journal-title":"Viruses"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01667-16","article-title":"MicroRNAs of epstein-barr virus control innate and adaptive antiviral immunity","volume":"91","author":"Albanese","year":"2017","journal-title":"J Virol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1159\/000479749","article-title":"Epstein-barr virus miR-BART6-3p inhibits the RIG-I pathway","volume":"9","author":"Lu","year":"2017","journal-title":"J Innate Immun"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200312","article-title":"Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production","volume":"189","author":"Haneklaus","year":"2012","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.molcel.2023.05.018","article-title":"An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation","volume":"83","author":"Yiu","year":"2023","journal-title":"Mol Cell"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11830","article-title":"NF-\u03baB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J Clin Invest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/v13020145","article-title":"The role of ubiquitination in NF-\u03baB signaling during virus infection","volume":"13","author":"Song","year":"2021","journal-title":"Viruses"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M505903200","article-title":"The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1","volume":"281","author":"Wu","year":"2006","journal-title":"J Biol Chem"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3390\/v5061587","article-title":"NF-\u03baB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1","volume":"5","author":"Ersing","year":"2013","journal-title":"Viruses"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02020-12","article-title":"Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-\u03baB signaling during productive replication","volume":"87","author":"Saito","year":"2013","journal-title":"J Virol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201901196RR","article-title":"Epstein-Barr virus tegument protein BGLF2 inhibits NF-\u03baB activity by preventing p65 Ser536 phosphorylation","volume":"33","author":"Chen","year":"2019","journal-title":"FASEB J"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/J.JBC.2023.104613","article-title":"Epstein-Barr virus envelope glycoprotein 110 inhibits NF-\u03baB activation by interacting with NF-\u03baB subunit p65","volume":"299","author":"Cai","year":"2023","journal-title":"J\u00a0Biol Chem"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.07.020","article-title":"BZLF1, an Epstein\u2013Barr virus immediate\u2013early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function","volume":"328","author":"Morrison","year":"2004","journal-title":"Virology"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01918-12","article-title":"Epstein-Barr virus BGLF4 kinase downregulates NF-\u03baB transactivation through phosphorylation of coactivator UXT","volume":"86","author":"Chang","year":"2012","journal-title":"J Virol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01099-08","article-title":"Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway","volume":"83","author":"Wang","year":"2009","journal-title":"J\u00a0Virol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080309","article-title":"EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression","volume":"111","author":"Guasparri","year":"2008","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0402135101","article-title":"Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway","volume":"101","author":"Stewart","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.2008\/003392-0","article-title":"Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis","volume":"89","author":"O\u2019Neil","year":"2008","journal-title":"vitro. J Gen Virol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-1","article-title":"Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation","volume":"9","author":"Valentine","year":"2010","journal-title":"Mol Cancer"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00530-17","article-title":"An epstein-barr virus microRNA blocks interleukin-1 (IL-1) signaling by targeting IL-1 receptor 1","volume":"91","author":"Skinner","year":"2017","journal-title":"J Virol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00752-08","article-title":"Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence","volume":"82","author":"Lu","year":"2008","journal-title":"J Virol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5126","article-title":"EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020023","article-title":"Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed","volume":"2","author":"Cai","year":"2006","journal-title":"PloS Pathog"},{"key":"B140","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1371\/journal.ppat.1001063","article-title":"Micro RNAS of epstein-barr virus promote cell cycle progression and prevent apoptosis of primary human B cells","volume":"6","author":"Seto","year":"2010","journal-title":"PloS Pathog"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.09.015","article-title":"The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis","volume":"512","author":"Poling","year":"2017","journal-title":"Virology"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/S11262-023-02006-X\/FIGURES\/2","article-title":"Genetic variability and mutation of Epstein-Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines","volume":"59","author":"Wang","year":"2023","journal-title":"Virus Genes"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/v13020300","article-title":"The role of NK cells in EBV infection and EBV-associated NPC","volume":"13","author":"Png","year":"2021","journal-title":"Viruses"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6437057","article-title":"Research progress on NK cell receptors and their signaling pathways","volume":"2020","author":"Chen","year":"2020","journal-title":"Mediators Inflammation"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00323","article-title":"NK Cell influence on the Outcome of Primary epstein\u2013Barr virus infection","volume":"7","author":"Chijioke","year":"2016","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1183788\/BIBTEX","article-title":"Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas","volume":"14","author":"Vietzen","year":"2023","journal-title":"Front Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic\u00a0epstein-barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301046","article-title":"A distinct subpopulation of human NK cells restricts B cell transformation by EBV","volume":"191","author":"L\u00fcnemann","year":"2013","journal-title":"J Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14045","article-title":"Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-\u03b3","volume":"8","author":"Jud","year":"2017","journal-title":"Oncotarget"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02105-17","article-title":"Herpesvirus evasion of natural killer cells","volume":"92","author":"De Pelsmaeker","year":"2018","journal-title":"J Virol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-143727","article-title":"MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response","volume":"112","author":"Yawata","year":"2008","journal-title":"Blood"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.90.18.8479","article-title":"Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death","volume":"90","author":"Henderson","year":"1993","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1000341","article-title":"An epstein-barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the wp\/BHRF1 link","volume":"5","author":"Kelly","year":"2009","journal-title":"PloS Pathog"},{"key":"B156","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/JVI.01932-15","article-title":"Induction of the lytic cycle sensitizes epstein-barr virus-infected B cells to NK cell killing that is counteracted by virus-mediated NK cell evasion mechanisms in the late lytic cycle","volume":"90","author":"Williams","year":"2016","journal-title":"J Virol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2020.1758416","article-title":"BHRF1, a BCL2 viral homolog, disturbs mitochondrial dynamics and stimulates mitophagy to dampen type I IFN induction","volume":"17","author":"Vilmen","year":"2021","journal-title":"Autophagy"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2292","article-title":"EBV infection in epithelial Malignancies induces resistance to antitumor natural killer cells via F3-mediated platelet aggregation","volume":"82","author":"Duan","year":"2022","journal-title":"Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1004906","article-title":"Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8+ T cells","volume":"11","author":"Rancan","year":"2015","journal-title":"PloS Pathog"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02243-21","article-title":"The epstein-barr virus oncogene EBNA1 suppresses natural killer cell responses and apoptosis early after infection of peripheral B cells","volume":"12","author":"Westhoff Smith","year":"2021","journal-title":"mBio"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/S00441-017-2763-0","article-title":"Neutrophils in viral infection","volume":"371","author":"Naumenko","year":"2018","journal-title":"Cell\u00a0Tissue Res"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3390\/v11020168","article-title":"Myeloid cells during viral infections and inflammation","volume":"11","author":"Stegelmeier","year":"2019","journal-title":"Viruses"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.01513\/BIBTEX","article-title":"The role of dendritic cells during infections caused by highly prevalent viruses","volume":"11","author":"Soto","year":"2020","journal-title":"Front Immunol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijid.2020.09.1300","article-title":"Macrophage\u2019s role in the microenvironmentgainst Epstein Barr Virus (EBV) in tonsils from pediatrics patients","volume":"101","author":"Moyano","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PloS Pathog"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005611","article-title":"Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells","volume":"137","author":"Collins","year":"2021","journal-title":"Blood"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.2020008640","article-title":"EBV and myeloid-derived suppressor cells","volume":"137","author":"Sinha","year":"2021","journal-title":"Blood"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.6.2612-2619.2000","article-title":"Infection of primary human monocytes by Epstein-Barr virus","volume":"74","author":"Savard","year":"2000","journal-title":"J Virol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.4049\/JIMMUNOL.164.12.6467","article-title":"EBV suppresses prostaglandin E2 biosynthesis in human monocytes","volume":"164","author":"Savard","year":"2000","journal-title":"J Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/15548627.2018.1536530","article-title":"EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation","volume":"15","author":"Gilardini Montani","year":"2019","journal-title":"Autophagy"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/JOURNAL.PONE.0011908","article-title":"Epstein-barr virus interferes with the amplification of IFN\u03b1 Secretion by activating suppressor of cytokine signaling 3 in primary human monocytes","volume":"5","author":"Michaud","year":"2010","journal-title":"PloS One"},{"key":"B172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1413-8670(12)70269-6","article-title":"Effects of Epstein-Barr virus on the development of dendritic cells derived from cord blood monocytes: an essential role for apoptosis","volume":"16","author":"Wang","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1182\/BLOODADVANCES.2018025536","article-title":"Plasmacytoid\u00a0dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile","volume":"3","author":"Gujer","year":"2019","journal-title":"Blood Adv"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIV340","article-title":"Cytokine-mediated loss of blood dendritic cells during epstein-barr virus\u2013associated acute infectious mononucleosis: implication for immune dysregulation","volume":"212","author":"Panikkar","year":"2015","journal-title":"J Infect Dis"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.7.2789.bloodjournal8672789","article-title":"Epstein-Barr virus modulates de novo protein synthesis in human neutrophils","volume":"86","author":"Beaulieu","year":"1995","journal-title":"Blood"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.1.291.413k34_291_299","article-title":"Epstein-Barr virus infects and induces apoptosis in human neutrophils","volume":"92","author":"Larochelle","year":"1998","journal-title":"Blood"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102462","article-title":"EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail","volume":"190","author":"Griffin","year":"2013","journal-title":"J Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802686","article-title":"Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.40.9.948","article-title":"The HLA system: structure and function","volume":"40","author":"Bodmer","year":"1987","journal-title":"Journal of Clinical Pathology"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605884113","article-title":"Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells","volume":"113","author":"Albanese","year":"2016","journal-title":"Proc\u00a0Natl Acad Sci U.S.A."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.657387","article-title":"Immune escape by non-coding RNAs of the epstein barr virus","volume":"12","author":"M\u00fcnz","year":"2021","journal-title":"Front Microbiol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160248","article-title":"Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing","volume":"213","author":"Tagawa","year":"2016","journal-title":"J Exp Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11262-022-01940-6","article-title":"The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis","volume":"59","author":"Liang","year":"2023","journal-title":"Virus Genes"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004322","article-title":"Cooperation between epstein-barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle","volume":"10","author":"Quinn","year":"2014","journal-title":"PloS Pathog"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2034960100","article-title":"Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition","volume":"100","author":"Ressing","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PPAT.1005550","article-title":"The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells","volume":"12","author":"Gram","year":"2016","journal-title":"PloS Pathog"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1086\/517260","article-title":"Viral interleukin-10 in chronic active epstein-barr virus infection","volume":"176","author":"Kanegane","year":"1997","journal-title":"JID"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":". Nat Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1128\/JVI","article-title":"Epstein-barr virus (EBV) tegument protein BGLF2 suppresses type I interferon signaling to promote EBV reactivation","volume":"94","author":"Liu","year":"2020","journal-title":"Journal of Virology"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00602-08","article-title":"Epstein-barr virus LF2: an antagonist to type I interferon","volume":"83","author":"Wu","year":"2009","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1297994\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:11:18Z","timestamp":1707264678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1297994\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":191,"alternative-id":["10.3389\/fimmu.2024.1297994"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1297994","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"article-number":"1297994"}}